Tag: digital biomarkers
App Characteristics and Accuracy Metrics of Available Digital Biomarkers for Autism: Scoping Review
Background: Diagnostic delays in autism are common, with the time to diagnosis being up to 3 years from the onset of symptoms. Such delays have a proven detrimental effect on individuals and families going…
Continue ReadingEmpatica Awarded New FDA Clearance for Cardiac Digital Biomarkers
Empatica receives US Food and Drug Administration (FDA) 510(k) clearance for two new digital biomarkers for its Empatica Health Monitoring Platform
What You Should Know:
– Empatica, a digital health and AI company, has obtained FDA…
Continue Reading23andMe Launches Health Action Plan Based on Genetic/Health Data
What You Should Know:
– 23andMe, a genetic health and biopharmaceutical company launched Health Action Plan, a new digital tool for 23andMe+ members that draws on results from genetic reports, health history survey data, as…
Continue ReadingThe Future of Biomarker-Based Therapy for Mental Disorder Care
Oded Kraft, Co-Founder & CEO of GrayMatters Health
We are living in a mental health epidemic. An estimated 26 percent of Americans ages 18 and older – about one in four adults – suffer from…
Continue ReadingThe latest innovations in digital devices and measures
Digital biomarkers – data collected by wearable digital medical devices – can be used to inform the development of new drugs and medical devices and to evaluate their effectiveness. Listen as Jordan Brayanov and…
Continue ReadingObjective wearable measures correlate with self-reported chronic pain levels in people with spinal cord stimulation systems
Spinal Cord Stimulation (SCS) is a well-established therapy for treating chronic pain. However, perceived treatment response to SCS therapy may vary among people with chronic pain due to diverse needs and backgrounds. Patient Reported…
Continue ReadingUniversity of Edinburgh joins collaborative for dementia digital solutions
The University of Edinburgh has joined the NEURii collaboration, which will explore the use of data and digital solutions to complement treatment options for people living with dementia. NEURii hopes to solve issues that…
Continue ReadingHackensack Meridian Health Partners with AI-Powered Speech Analysis Start-Up for Vocal Biomarker Technology
Hackensack Meridian Health has partnered with Canary Health, an AI-driven speech analysis start-up, to develop vocal biomarker technology for screening anxiety and cognitive diseases. Canary Speech’s proprietary machine learning models assess digital biomarkers in…
Continue ReadingHackensack Meridien Health partners with AI-driven speech analysis start-up
Health system Hackensack Meridian Health is partnering with Canary Health, which uses proprietary machine learning modeling to assess digital biomarkers in the human voice to explain or predict health-related outcomes. This will enable Hackensack…
Continue Reading